HUG International Symposium on Helicobacter & Upper GI Diseases

International Symposium on Helicobacter & Upper GI Diseases

HUG 2026 – Translational Advances in Helicobacter Research
March 19-22, 2026
Register / Abstract Submission

About the Symposium

The HUG International Symposium brings together world-leading experts and researchers in Helicobacter pylori and upper gastrointestinal diseases. The program explores cutting-edge science, clinical advances, and future strategies in diagnosis, treatment, and prevention.

Symposium Agenda March 19 (Highlights)

TimeSessionSpeaker / Topic
09:00-10:30 Symposium 1: Asia-Pacific Forum Distinguished research updates on H. pylori infection
13:00-14:20 Symposium 2 Recent advancements in gastric cancer research
14:40-15:40 Symposium 3 Updates on management of Helicobacter pylori
16:00-17:00 Symposium 4 Current status and challenges in upper GI diseases

Symposium Agenda March 20 (Highlights)

TimeSessionSpeaker / Topic
09:50-10:40 Symposium 5 Past, present, and future of global collaboration in Helicobacter Research
11:00-12:00 Symposium 6 Gut microbiome and gastric carcinogenesis

Symposium Agenda March 21 (Highlights)

TimeSessionSpeaker / Topic
10:20-11:20 Symposium 7 Gastric cancer after Helicobacter eradication

Program Details

Important Information

The deadline for abstract submission is 12/01/2026. Participants are advised to complete online registration before the pre-registration deadline to benefit from reduced fees.

Notification of Abstract Acceptance: February 2 (Mon), 2026

Pre-Registration Deadline: February 19 (Thu), 2026

Official language of the Symposium is English.

More details & full program on the official website

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959